Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
55.4
64
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Other Liabilities
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Other Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
|
Other Liabilities
ď·Ľ219m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dallah Healthcare Company SJSC
SAU:4004
|
Other Liabilities
ď·Ľ279.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
17%
|
CAGR 10-Years
15%
|
|
|
National Medical Care Company JSC
SAU:4005
|
Other Liabilities
ď·Ľ101.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
Mouwasat Medical Services Company SJSC
SAU:4002
|
Other Liabilities
ď·Ľ205.3m
|
CAGR 3-Years
20%
|
CAGR 5-Years
19%
|
CAGR 10-Years
18%
|
|
|
A
|
Al Hammadi Holding Co
SAU:4007
|
Other Liabilities
ď·Ľ195.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
28%
|
|
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
Other Liabilities
ď·Ľ687.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Glance View
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC is a SA-based company operating in Health Care Providers & Services industry. The company is headquartered in Jeddah, Makkah. The company went IPO on 2024-06-05. Dr. Soliman Fakeeh Hospital (DSFH) is a Saudi Arabia-based company. The firm is engaged in operating private hospitals and clinics. The company offers its medical services through six units: the Specialty Units, which include burn care unit, renal dialysis unit, extended care unit, In vitro fertilization lab, extra corporeal shock wave lithotripsy (ESWL Unit), hyperbaric oxygen unit, bone marrow transplant unit, organ transplantation center, allergy, immunology and respiratory and sleep disorders unit (AIRS Unit); Laboratory Unit, which includes pathology section, hematological diagnosis laboratory, toxicology and drug monitoring laboratory, microbiology laboratory and virology laboratory; Executive Health Program, which is a personalized health Program, offering a range of consultations, investigations and diagnostic procedures; Clinical Department, which includes internal medicine, obstetrics & gynecology, pediatrics, general surgery and anesthesia, among others; Pharmacy, and Radiology.
See Also
What is Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's Other Liabilities?
Other Liabilities
219m
SAR
Based on the financial report for Dec 31, 2023, Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's Other Liabilities amounts to 219m SAR.
What is Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's Other Liabilities growth rate?
Other Liabilities CAGR 1Y
6%
Over the last year, the Other Liabilities growth was 6%.
You don't have any saved screeners yet
